VivoSim Labs, Inc. VIVS
Set alert
0.15 USD 0.00 -1.97%
At close · Oct 30
0.15 0.00 +0.19%
After hours · Oct 30, 5:16 PM ET
0.1423 Day range 0.1549
0.15 52-week range 2.98
- YTD
- -91.46%
- 1 year
- -94.81%
- Open
- 0.15
- Prev close
- 0.1577
- Mkt cap
- 2.56M
- Vol
- 755.87K
- Avg vol
- 2.77M
- EPS
- -4.47
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1423
- High
- 0.1549
MAX chart
Signals (36)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Feb 1, 2026 | 9 months ago |
| SMA: Bullish | Jan 1, 2026 | 10 months ago |
| SMA: Bearish | Mar 1, 2025 | 1 year ago |
| SMA: Bullish | Feb 1, 2025 | 1 year ago |
| RSI: Oversold | Jan 1, 2025 | 1 year ago |
| RSI: Oversold | Oct 1, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2023 | 3 years ago |
| SMA: Bullish | Feb 1, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 1, 2022 | 4 years ago |
| MACD: Sell Signal | Jan 1, 2022 | 4 years ago |
| SMA: Bearish | Mar 1, 2021 | 5 years ago |
| SMA: Bearish | Mar 1, 2021 | 5 years ago |
| SMA: Bullish | Jan 1, 2021 | 5 years ago |
| SMA: Bullish | Dec 1, 2020 | 5 years ago |
| SMA: Bearish | Aug 1, 2020 | 6 years ago |
| SMA: Bullish | Mar 1, 2020 | 6 years ago |
| MACD: Buy Signal | Nov 1, 2019 | 7 years ago |
| MACD: Sell Signal | Aug 1, 2019 | 7 years ago |
| SMA: Bearish | Jun 1, 2018 | 8 years ago |
| MACD: Buy Signal | Jun 1, 2018 | 8 years ago |
| SMA: Bullish | May 1, 2018 | 8 years ago |
| MACD: Sell Signal | Jul 1, 2017 | 9 years ago |
| SMA: Bearish | Feb 1, 2017 | 9 years ago |
| SMA: Bullish | Dec 1, 2016 | 9 years ago |
| SMA: Bearish | Oct 1, 2016 | 10 years ago |
| MACD: Buy Signal | Jul 1, 2016 | 10 years ago |
| SMA: Bullish | Apr 1, 2016 | 10 years ago |
| SMA: Bearish | Feb 1, 2015 | 11 years ago |
| SMA: Bearish | Jan 1, 2015 | 11 years ago |
| SMA: Bullish | Dec 1, 2014 | 11 years ago |
| SMA: Bearish | Jul 1, 2014 | 12 years ago |
| SMA: Bullish | Jun 1, 2014 | 12 years ago |
| SMA: Bearish | Apr 1, 2014 | 12 years ago |
| RSI: Overbought | Feb 1, 2014 | 12 years ago |
| RSI: Overbought | Oct 1, 2013 | 13 years ago |
| SMA: Bullish | Jan 1, 2013 | 13 years ago |
Financials — quick view
VIVS Revenue — quarterly 18.00K
VIVS Net income — quarterly -1.34M
VIVS EPS — quarterly -0.25
News
- VivoSim Labs To Extend Its Human Tissue Platform Beyond Toxicology With Efficacy Testing Services Built On NAMkind Disease Models Of The Liver And Intestine
- VivoSim Labs Extends NAMkind Platform with Human Disease Models for Efficacy Testing and Mechanistic Biomarker Profiling
- 12 Health Care Stocks Moving In Monday's After-Market Session
- Vivosim Labs Notes FDA's Direct Final Rule Clarifying That Non-Animal Methods Can Be Used Where Appropriate For Testing Safety Of Drugs And Biological Products For Human Use
- VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods
- VivoSim Labs (NASDAQ:VIVS) vs. iSpecimen (NASDAQ:ISPC) Head to Head Comparison
- VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs
- VivoSim Labs Plans To Develop Rat Liver Model To Complement Existing NAMkind Human Liver Platform And Expand Its Liver Toxicology Capabilities
- VivoSim Labs to Add Rat Liver Model to NAMkind Platform
- Why Avalon Holdings Shares Are Trading Higher By More Than 10%; Here Are 20 Stocks Moving Premarket
Your note
Sign in to keep a note on VIVS — it syncs with the Stock Master app.